Εξώφυλλο

Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-α) in Anemia Associated with Chronic Kidney Disease (CKD) Patients

Background: Anemia due to chronic kidney disease (CKD) is often associated with decreased erythropoietin (EPO) levels in the blood. Treatments available are improving blood iron levels and administration of exogenous EPO (rhEPO). This study aims to assess the safety and immunogenicity of Epodion, a...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Nova Angginy (Συγγραφέας), Chang Woo Suh (Συγγραφέας), Jonny Jonny (Συγγραφέας), Nuly Juariah Mahnulia (Συγγραφέας), Suhardjono Suhardjono (Συγγραφέας)
Μορφή:	Βιβλίο
Έκδοση:	Interna Publishing, 2022-07-01T00:00:00Z.
Θέματα:	article
Διαθέσιμο Online:	Connect to this object online.
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Clinical Comparison of Renogen, a Biosimilar Epoetin-a, with the Originator, Eprex, in Chronic Kidney Disease Anemia in Indonesia: A Preliminary Study
από: Ni Made Hustrini, κ.ά.
Έκδοση: (2019)

Association of BsmI Polymorphisms in the Vitamin D Receptor Gene Among Indonesian Population with Diabetic Kidney Disease
από: Pringgodigdo Nugroho, κ.ά.
Έκδοση: (2021)

Recombinant human epoetin beta in the treatment of chemotherapy-related anemia
από: Iain RJ Macpherson, κ.ά.
Έκδοση: (2009)

Comparison of Quality of Life between Patients Undergoing Chronic Hemodialysis with Reusable Dialyzer and Single-Use Dialyzer: A Retrospective Cohort Study
από: Lucky Aziza Bawazier, κ.ά.
Έκδοση: (2018)

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis
από: Ha-Young Na, κ.ά.
Έκδοση: (2014)

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
από: Shimamatsu K
Έκδοση: (2014)

Acute Kidney Injury and Jaundice in a Patient With Concurrent Severe Malaria and Acute Exacerbation of Hepatitis B
από: Jonny Jonny MD, κ.ά.
Έκδοση: (2021)

Shift in Balance of IV Iron-to-Epoetin USE: 2008-2011
από: Alex Yang, κ.ά.
Έκδοση: (2012)

Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
από: Hendrik Wessels, κ.ά.
Έκδοση: (2019)

Comorbidities in Chronic Kidney Disease (CKD)
Έκδοση: (2021)

The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta
από: Ni Made Hustrini, κ.ά.
Έκδοση: (2023)

Iron supplements concomitant with HIF-PHIs in the treatment of CKD anemia
από: Xue Wang, κ.ά.
Έκδοση: (2023)

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects
από: Karsten Roth, κ.ά.
Έκδοση: (2019)

Epoetin alfa ja namaluva nefrotoksicnosta inducirana so cisplatin kaj staorci
από: Dimce Zafirov, κ.ά.
Έκδοση: (2006)

COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease
από: Juan León Román, κ.ά.
Έκδοση: (2021)

DOSE ADJUSTMENT PRACTICES OF PEGINESATIDE VS. EPOETIN IN EMERALD 1 AND 2 PIVOTAL TRIALS
από: Amit Sharma, κ.ά.
Έκδοση: (2012)

Acute Kidney Injury and Hypothyroidism in a Patient with CKD
από: Preeti Chandra, κ.ά.
Έκδοση: (2022)

Pediatric Acute Kidney Injury to the Subsequent CKD Transition
από: Fang Wang, κ.ά.
Έκδοση: (2020)

Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Development of Drugs on Endothelial Cell Protection for Overcoming CKD
από: Keisuke Ishizawa, κ.ά.
Έκδοση: (2009)

Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD)
από: Sung Woo Lee, κ.ά.
Έκδοση: (2017)

Factors Associated with Sarcopenia in Maintenance Hemodialysis Patients: A Cross-Sectional Study
από: Ria Jauwerissa, κ.ά.
Έκδοση: (2023)

Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects
από: Hanjing Chen, κ.ά.
Έκδοση: (2022)

Topical Administration of a Nanoformulation of Chitosan-Hyaluronic Acid-Epoetin Beta in a Rat Model of Glaucoma
από: Beatriz Silva, κ.ά.
Έκδοση: (2023)

A Complexity-Based Plan for Evaluating Transformation
από: Jonny Morell
Έκδοση: (2023)

Uji Validitas Konstruk Leader Member Eexchange - Multi-Dimensional Measure (LMX-MDM)
από: Jonny Pranata
Έκδοση: (2016)

Uji Validitas Konstruk Leader Member Exchange - Multi-Dimensional Measure (LMX-MDM)
από: Jonny Pranata
Έκδοση: (2019)

Chapter 10 The Ethics of Genetic Enhancement Key Concepts and Future Prospects
από: Anomaly, Jonny
Έκδοση: (2024)

Ansvarlighet i samarbeidet mellom ansatte og beboere i et kommunalt bofellesskap
από: Jonny Mækelæ
Έκδοση: (2015)

The vasodilation effects of curcumin and its derivatives on isolated aortic of rats
από: Agung Endro Nugroho, κ.ά.
Έκδοση: (2008)

Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
από: Zhen Zeng, κ.ά.
Έκδοση: (2024)

Drug Discovery for Overcoming Chronic Kidney Disease (CKD): New Therapy for CKD by a (Pro)Renin-Receptor-Blocking Decoy Peptide
από: Atsuhiro Ichihara, κ.ά.
Έκδοση: (2009)

Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD)
από: Christina L. Nelms, κ.ά.
Έκδοση: (2018)

Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis
από: Rui Hu, κ.ά.
Έκδοση: (2023)

Predictive Value of Serum Hepcidin Levels for the Risk of Incident End-Stage Kidney Disease in Patients with Chronic Kidney Disease: The KNOW-CKD
από: Sang Heon Suh, κ.ά.
Έκδοση: (2024)

Drug Discovery for Overcoming Chronic Kidney Disease (CKD): The Endothelin ETB Receptor / Nitric Oxide System Functions as a Protective Factor in CKD
από: Mamoru Ohkita, κ.ά.
Έκδοση: (2009)

Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
από: Kohji Ohki, κ.ά.
Έκδοση: (2020)

Urine Osmolality and Renal Outcome in Patients with Chronic Kidney Disease: Results from the KNOW-CKD
από: Mi Jung Lee, κ.ά.
Έκδοση: (2019)

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
από: Colbert GB, κ.ά.
Έκδοση: (2023)

A National Strategy for Kidney Health Promotion and Quality Management in CKD is Needed
από: Anabela Rodrigues
Έκδοση: (2023)

Barriers to management of Chronic Kidney Disease (CKD) CKD in a renal clinic in KwaZulu-Natal Province, South Africa - A qualitative study
από: Geldine Chironda, κ.ά.
Έκδοση: (2019)